Value

All articles by Value

W2O acquires value and payment consulting firm Discern Health
W2O acquires value and payment consulting firm Discern Health
Alison Kanski
July 28, 2020
10:00 am

This is W2O’s six acquisition in less than a year.

Entresto, nihilism and value-based contracting
Entresto, nihilism and value-based contracting
Marc Iskowitz
May 21, 2019
11:51 am

A postmortem on the Entresto launch reveals some lessons in value-based contracting.

Cassidy, Warner draft bill to promote value-based payment models
Cassidy, Warner draft bill to promote value-based payment models
Alison Kanski
January 31, 2019
10:48 am

Senators Bill Cassidy and Mark Warner are taking feedback from the public before introducing the bill.

Precision for Value puts Maureen Hennessey at helm of new value strategy practice
Precision for Value puts Maureen Hennessey at helm of new value strategy practice
Alison Kanski
January 30, 2019
10:21 am

The practice will work with clients to create customized education and training programs

Biogen, Merck use predictive modeling to better negotiate value-based contracts
Biogen, Merck use predictive modeling to better negotiate value-based contracts
Kevin McCaffrey
August 15, 2017
11:00 am

What’s holding back value-based pricing deals from moving beyond the pilot phase?

On Shkreli, Here Are the Lessons for Pharma to Learn and Apply
On Shkreli, Here Are the Lessons for Pharma to Learn and Apply
Gil Bashe, Finn Partners
August 7, 2017
12:55 pm

Though Shkreli may soon slip from the public eye, separated from his Twitter account and prohibited from trading securities, pharma communicators must learn from these events.

Five things for pharma marketers to know: Tuesday, July 11, 2017
Five things for pharma marketers to know: Tuesday, July 11, 2017
Virginia Lau
July 11, 2017
2:09 pm

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

Five things for pharma marketers to know: Tuesday, May 30, 2017
Five things for pharma marketers to know: Tuesday, May 30, 2017
Jaimy Lee
May 30, 2017
2:20 pm

Harvard Pilgrim signs two outcomes contracts with AstraZeneca; lobbyists fight over drug-pricing proposals; docs say no to adult ADHD screening test

Value-based care requires innovators to challenge the status quo
Value-based care requires innovators to challenge the status quo
Larry Dobrow
May 2, 2017
12:25 pm

Execs stressed the importance of collaboration, consumer-mindedness.

Five things for pharma marketers to know: Thursday, April 27, 2017
Five things for pharma marketers to know: Thursday, April 27, 2017
Jaimy Lee
April 27, 2017
1:30 pm

Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients

  • From Our Partners